The FDA will collaborate with the Alliance for NanoHealth to speed creation of safe nanotechnology medical products. The cooperation between the FDA and the alliance's eight member institutions will “expand knowledge of how nanoparticles behave and affect biologic systems, and will facilitate the development of tests and processes that might mitigate the risks associated with nanoengineered products.”

The alliance's eight academic institutions are the Baylor College of Medicine, the University of Texas M.D. Anderson Cancer Center, Rice University, the University of Houston, the University of Texas Health Science Center at Houston, Texas A & M Health Science Center, the University of Texas Medical Branch at Galveston and the Methodist Hospital Research Institute in Houston.